gra_bdoctor.jpg   Everyone knew there was a connection for decades …  Yet tobacco companies hired “scientists”, who said, not only that there was no connection between Cancer and smoking, they even made claims that smoking was healthful!

So,  … as Solomon wrote … ‘there’s nothing new under the sun’, (a paraphrase from Ecclesiastes 1:9) …

And potheads?  They’re doing the same things, . . . along with the greedy and the criminally minded, . . . they continue to promote legalization of pot and mimic the tobacco company ‘czars’ – they still hire bogus scientists and buy off doctors, but they’re doing so, while they’ve got their heads where the sun doesn’t shine!

They claim all of the science, proves pot is harmless, even medicinal!   They also claim that our side lies – – – that (other than theirs) there is no current ongoing research for the truth.   It’s easy to tell which side is telling the truth when looking at “motivation”!

Most all of us have lost a loved one to drug use!  We’re right out front with our motivation: We seek to end the harm done!   They want their “hedonistic” practices made legal …

Reading their plans, … theirs is to legalize all drugs; they admit that, and reveal their plan is to begin with marijuana …

But, … here’s the truth!

DARE TO LOOK – SCROLL DOWN to see how many new studies show the harmful nature of POT just this month!

   Listed below, are some an ongoing pursuit for truth — this month’s scientific studies … most all published are related to marijuana use — which they, and of course also the MSM – (mainstream media) do their best to supress: 

1. Critical limb ischemia in a young man: saddle embolism or unusual presentation of thromboangiitis obliterans?
Bucci F, Redler A, Fiengo L.
Case Rep Vasc Med.         2013
2. IBD: Patients with         IBD find symptom relief in the Cannabis field.
Schicho R, Storr M.
Nat Rev Gastroenterol         Hepatol. 2013 Dec 24. doi: 10.1038/nrgastro.2013.245. [Epub ahead         of print] No abstract available.
3. Cannabis Use Expectancies Mediate the Relation Between Depressive Symptoms and Cannabis Use Among Cannabis-Dependent Veterans.
Farris SG, Zvolensky MJ, Boden MT, Bonn-Miller         MO.
J Addict Med. 2013 Dec
4. Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis.
Morgan VA, McGrath JJ, Jablensky A, Badcock JC,         Waterreus A, Bush R, Carr V, Castle D, Cohen M, Galletly C, Harvey C,         Hocking B, McGorry P, Neil AL, Saw S, Shah S, Stain HJ, Mackinnon         A.
Psychol Med. 2013 Dec
5. Endocannabinoid         signalling in neuronal migration.
Zhou Y, Falenta K, Lalli G.
Int J Biochem Cell Biol. 2013
6. Cannabis Finds Its Way into Treatment of Crohn’s Disease.
Schicho R, Storr M.
7. Cannabinoid Hyperemesis Syndrome: cyclical vomiting behind the cloud of smoke.
Williamson JE, July M, Gonzalez LM, Amin HH,         Chaudhari S.
Am J Med. 2013 Dec 16
8. Association of Marijuana Smoking with Oropharyngeal and Oral Tongue Cancers: Pooled Analysis from the INHANCE Consortium.
Marks MA, Chaturvedi AK, Kelsey K, Straif K,         Berthiller J, Schwartz SM, Smith E, Wyss A, Brennan P, Olshan AF, Wei Q,         Sturgis EM, Zhang ZF, Morgenstern H, Muscat J, Lazarus P, McClean M,         Chen C, Vaughan TL, Wunsch-Filho V, Curado MP, Koifman S, Matos E,         Menezes A, Daudt AW, Fernandez L, Posner M, Boffetta P, Lee YC, Hashibe         M, D’Souza G.
Cancer Epidemiol Biomarkers
9. Identity Formation, Marijuana and “The Self”: A Study of Cannabis Normalization among University Students.
Mostaghim A, Hathaway AD.
Front Psychiatry. 2013 Dec
10. Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users.
Di Forti M, Sallis H, Allegri F, Trotta A, Ferraro L,         Stilo SA, Marconi A, La Cascia C, Reis Marques T, Pariante C, Dazzan P,         Mondelli V, Paparelli A, Kolliakou A, Prata D, Gaugrhan F, David AS,         Morgan C, Sthal D, Khondoker M, Maccabe JH, Murray     RM.
Schizophr Bull. 2013
Related         citations
11. Drug polyconsumption is associated with increased synchronization of brain electrical-activity at rest and in a counting task.
Coullaut-Valera R, Arbaiza I, Bajo R, Arrúe R, López         ME, Coullaut-Valera J, Correas A, López-Sanz D, Maestu F, Papo         D.
Int J Neural Syst. 2014
PMID: 24344693
12. The Role of Constraint in the Development of Nicotine, Marijuana, and Alcohol Dependence in Young Adulthood.
Vrieze SI, Vaidyanathan U, Hicks BM, Iacono WG, McGue         M.
Behav Genet. 2013 Dec
13. [Clinical prognosis of schizophrenic patients with cannabis addiction : Between nihilism and hope.]
Schnell T.
Nervenarzt. 2013 Dec
14. Cannabis-Related Working Memory Deficits and Associated Subcortical Morphological Differences in Healthy Individuals and Schizophrenia Subjects.
Smith MJ, Cobia DJ, Wang L, Alpert KI, J Cronenwett         W, B Goldman M, Mamah D, Barch DM, Breiter HC, Csernansky         JG.
Schizophr Bull. 2013 Dec
15. Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: A national study.
Wu LT, Brady KT, Mannelli P, Killeen TK;         NIDA AAPI Workgroup.
J Psychiatr Res. 2013 Dec 1. pii: S0022-3956(13)00360-9. doi: 10.1016/j.jpsychires.2013.11.010.
16. Developmental trajectories of marijuana use from adolescence to adulthood: Relationship with using weapons including guns.
Brook JS, Lee JY, Finch SJ, Brook
Aggress Behav. 2013 Dec 16. doi: 10.1002/ab.21520.
17. Intentional Misuse of Over-the-Counter Medications, Mental Health, and Polysubstance Use in Young Adults.
Benotsch EG, Koester S, Martin AM, Cejka A, Luckman         D, Jeffers AJ.
J Community Health. 2013 Dec
18. High HIV risk in a         cohort of male sex workers from Nairobi, Kenya.
McKinnon LR, Gakii G, Juno JA, Izulla P, Munyao J,         Ireri N, Kariuki CW, Shaw SY, Nagelkerke NJ, Gelmon L, Musyoki H,         Muraguri N, Kaul R, Lorway R, Kimani J.
Sex Transm Infect. 2013 Dec 13. doi: 10.1136/sextrans-2013-051310
19. Uruguay legalises sale and production of marijuana.
Arie S.
BMJ. 2013 Dec 13;347:f7499.  doi: 10.1136/bmj.f7499. No abstract available.
20. Notes from the field: severe illness associated with reported use of synthetic marijuana – colorado, august-september 2013.
Centers for Disease Control and Prevention         (CDC).
21. Polytobacco use and multiple-product smoking among a random community sample of African-American adults.
Corral I, Landrine H, Simms DA, Bess         JJ.
BMJ Open. 2013 Dec
22. Reference ranges for urinary levels of testosterone and epitestosterone, which may reveal gonadal function, in a Korean male population.
Moon JY, Kwon W, Suh S, Cheong JC, In MK, Chung BC,         Kim JY, Choi MH.
J Steroid Biochem Mol Biol.  2013 Dec
23. Psychiatric symptom differences in people with schizophrenia associated with substantial lifetime substance use but no current substance use disorder.
Koola MM, Gorelick DA, McMahon RP, Liu F, Huestis MA,         Linthicum J, Feldman SM, Warren KR, Wehring HJ, Kelly       DL.
Schizophr Res. 2013 Dec 11.  No abstract available.
24. [Tobacco use by adolescents in Barcelona (Spain) and trends in the last 20 years.]
Ariza C, García-Continente X, Villalbí JR,         Sánchez-Martínez F, Pérez A, Nebot M.
Gac Sanit. 2013 Dec 11. pii:
25. Short-Term Mediating Factors of a School-Based Intervention to Prevent Youth Substance Use in Europe.
Giannotta F, Vigna-Taglianti F, Rosaria Galanti M,         Scatigna M, Faggiano F.
J Adolesc Health. 2013 Dec
26. Inequalities in Croatian pupils’ risk behaviors associated to socioeconomic environment at school and area level: A multilevel approach.
Pavic Simetin I, Kern J, Kuzman M, Pförtner         TK.
Soc Sci Med. 2013
27. The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance.
Pesta DH, Angadi SS, Burtscher M, Roberts         CK.
Nutr Metab (Lond). 2013 Dec
28. Prenatal exposure to the CB<sub>1</sub> and CB<sub>2</sub> cannabinoid receptor agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex.
Saez TM, Aronne MP, Caltana L, Brusco         AH.
J Neurochem. 2013 Dec
29. (Re)introducing medicinal cannabis.
Mather LE, Rauwendaal ER, Moxham-Hall VL, Wodak         AD.
Med J Aust. 2013 Dec        No abstract available.
30. Sexual Orientation, Gender, and Racial Differences in Illicit Drug Use in a Sample of US High School Students.
Newcomb ME, Birkett M, Corliss HL, Mustanski         B.
Am J Public Health. 2013 Dec
31. Concentrations of Cocaine and Benzoylecgonine in Femoral Blood from Cocaine-Related Deaths Compared with Venous Blood from Impaired Drivers.
Jones AW, Holmgren A.
J Anal Toxicol. 2013 Dec
32. Psychiatric profiles         of mothers who take Ecstasy/MDMA during pregnancy: Reduced depression 1         year after giving birth and quitting Ecstasy.
Turner JJ, Parrott AC, Goodwin J, Moore DG, Fulton S,         Min MO, Singer LT.
J Psychopharmacol. 2013 Dec
33. Cannabis use: a perspective in relation to the proposed UK drug-driving legislation.
Wolff K, Johnston A.
Drug Test Anal. 2013 Dec
34. Memory: A boost for medical marijuana?
Welberg L.
Nat Rev Neurosci. 2014
35. “King hit” fatalities in Australia, 2000-2012: The role of alcohol and other drugs.
Pilgrim JL, Gerostamoulos D, Drummer         OH.
Drug Alcohol Depend. 2013 Dec
36. Initial reactions to tobacco and cannabis smoking: A twin study.
Agrawal A, Madden PA, Bucholz KK, Heath AC, Lynskey         MT.
Addiction. 2013 Dec
37. Drug Use and Sexual Arrangements Among Gay Couples: Frequency, Interdependence, and Associations with Sexual Risk.
Parsons JT, Starks TJ.
Arch Sex Behav. 2013 Dec
38. Forensic investigation of K2, Spice, and “bath salt” commercial preparations: A three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds.
Seely KA, Patton AL, Moran CL, Womack ML, Prather PL,         Fantegrossi WE, Radominska-Pandya A, Endres GW, Channell KB, Smith NH,         McCain KR, James LP, Moran JH.
Forensic Sci Int. 2013 Dec
39. Use of illicit drugs by truck drivers arriving at Paranaguá port terminal, Brazil.
Peixe TS, de Almeida RM, Girotto E, de Andrade SM,         Mesas AE.
Traffic Inj Prev. 2013 Dec
40. Rates of fetal polydrug exposures in methadone-maintained pregnancies from a high-risk population.
Delano K, Gareri J, Koren G.
PLoS One. 2013 Dec
41. Sexual Scripts and Sexual Risk Behaviors Among Black Heterosexual Men: Development of the Sexual Scripts Scale.
Bowleg L, Burkholder GJ, Noar SM, Teti M, Malebranche         DJ, Tschann JM.
Arch Sex Behav. 2013 Dec
42. Seroprevalence of human immunodeficiency virus, Hepatitis B surface antigen, and Hepatitis C in substance dependents admitted in a tertiary hospital at Amritsar, India.
Chalana H, Singh H, Sachdeva JK, Sharma         S.
Asian J Psychiatr. 2013
43. A controlled family study of cannabis users with and without  psychosis.
Proal AC, Fleming J, Galvez-Buccollini JA, Delisi         LE.
Schizophr Res. 2013 Dec
44. Parent-Child Drug Communication: Pathway From Parents’ Ad Exposure to Youth’s Marijuana Use Intention.
Huansuriya T, Siegel JT, Crano     WD.
J Health Commun. 2013 Dec
45. Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice.
Pozzilli C.
Expert Rev Neurother. 2013 Dec
46. Substance use disorder among anesthesiology residents,  1975-2009.
Warner DO, Berge K, Sun H, Harman A, Hanson A,         Schroeder DR.
JAMA. 2013 Dec
47. In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis.
Desrosiers NA, Lee D, Scheidweiler KB,         Concheiro-Guisan M, Gorelick DA, Huestis MA.
Anal Bioanal Chem. 2013 Dec
48. Medical and nonmedical use of prescription stimulants: results from a national multicohort study.
McCabe SE, West BT.
J Am Acad Child Adolesc Psychiatry. 2013 Dec
49. Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study.
Barbeito S, Vega P, Ruiz de Azúa S, Saenz M,         Martinez-Cengotitabengoa M, González-Ortega I, Bermudez C, Hernanz M,         Corres BF, González-Pinto A.
BMC Psychiatry. 2013 Dec
50. Age at onset of schizophrenia: Cannabis, COMT gene, and their interactions.
De Sousa KR, Tiwari AK, Giuffra DE, Mackenzie B, Zai         CC, Kennedy JL.
Schizophr Res. 2013 Dec    No abstract available.
51. Commentary on Heron et al. (2013): Findings on associations between conduct problem trajectories, early risk factors and adolescent cannabis use-how do they fit with existing         theories?
Hemphill SA.
Addiction. 2013 Dec
52. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.
Porter BE, Jacobson C.
Epilepsy Behav. 2013 Dec
53. Medical marijuana for epilepsy: Winds of change.
Sirven JI.
Epilepsy Behav. 2013 Dec     No abstract available.
54. Medical consequences of marijuana use: a review of current  literature.
Gordon AJ, Conley JW, Gordon JM.
Curr Psychiatry Rep. 2013 Dec
55. Spice, pot, and stroke.
Brust JC.
Neurology. 2013 Dec
56. Ischemic stroke after use of the synthetic marijuana “spice”.
Freeman MJ, Rose DZ, Myers MA, Gooch CL, Bozeman AC,         Burgin WS.
Neurology. 2013 Dec
57. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
Fabritius M, Chtioui H, Battistella G, Annoni JM, Dao         K, Favrat B, Fornari E, Lauer E, Maeder P, Giroud C.
Anal Bioanal Chem. 2013 Dec
58. Association between cannabis use, psychosis, and schizotypal personality disorder: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
Davis GP, Compton MT, Wang S, Levin FR, Blanco         C.
Schizophr Res. 2013 Dec
59. Cardiac asystole following cannabis (marijuana) usage – Additional mechanism for sudden death?
Menahem S.
Forensic Sci Int. 2013 Dec
60. Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis.
Hjorthøj CR, Orlovska S, Fohlmann A, Nordentoft         M.
Schizophr Res. 2013 Dec
61. Marijuana use patterns among patients with inflammatory bowel disease.
Ravikoff Allegretti J, Courtwright A, Lucci M,         Korzenik JR, Levine J.
Inflamm Bowel Dis. 2013 Dec
62. Δ(8)-Tetrahydrocannabinol induces cytotoxicity in macrophage J774-1 cells: Involvement of cannabinoid receptor 2 and p38 MAPK.
Yamaori S, Ishii H, Chiba K, Yamamoto I, Watanabe         K.
Toxicology. 2013 Dec
63. [Cannabis and acute coronary syndrome with ST segment elevation].
Ghannem M, Belhadj I, Tritar A, Moukala T, Amri N,         Noury A, Zaghdoudi M.
Ann Cardiol Angeiol (Paris).         2013 Dec
64. The large spectrum of pulmonary complications following illicit drug use: Features and mechanisms.
Mégarbane B, Chevillard L.
Chem Biol Interact. 2013 Dec
65. The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review.
James A, James C, Thwaites T.
Psychiatry Res. 2013 Dec
66. White matter characterization of adolescent binge drinking with and without co-occurring marijuana use: A 3-year  investigation.
Jacobus J, Squeglia LM, Bava S, Tapert         SF.
Psychiatry Res. 2013 Dec
67. Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users.
van Wel JH, Kuypers KP, Theunissen EL, Toennes SW,         Spronk DB, Verkes RJ, Ramaekers JG.
Br J Pharmacol. 2013 Dec
68. C-reactive protein and substance use disorders in adolescence and early adulthood: a prospective analysis.
Costello EJ, Copeland WE, Shanahan L, Worthman CM,         Angold A.
Drug Alcohol Depend. 2013 Dec
69. Diuretic effects of cannabinoid agonists in mice.
Chopda GR, Vemuri VK, Sharma R, Thakur GA,         Makriyannis A, Paronis CA.
Eur J Pharmacol. 2013 Dec
70. Electrophysiological evidence of atypical processing underlying mental set shifting in ecstasy polydrug and polydrug users.
Roberts CA, Fairclough SH, McGlone FP, Fisk JE,         Montgomery C.
Exp Clin Psychopharmacol.         2013 Dec
71. What do you feel? Adolescent drug and alcohol users show altered brain response to pleasant interoceptive stimuli.
Migliorini R, Stewart JL, May AC, Tapert SF, Paulus         MP.
Drug Alcohol Depend. 2013 Dec
72. Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people.
Wu LT, Blazer DG, Gersing KR, Burchett B, Swartz MS,         Mannelli P; NIDA AAPI Workgroup.
J Psychiatr Res. 2013 Dec
73. Cannabinoids in Exhaled Breath following Controlled Administration of Smoked Cannabis.
Himes SK, Scheidweiler KB, Beck O, Gorelick DA,         Desrosiers NA, Huestis MA.
Clin Chem. 2013 Dec.
74. Days of heroin use predict poor self-reported health in hospitalized heroin users.
Meshesha LZ, Tsui JI, Liebschutz JM, Crooks D,         Anderson BJ, Herman DS, Stein MD.
Addict Behav. 2013 Dec
75. Facilitators and barriers in treatment seeking for cannabis  dependence.
van der Pol P, Liebregts N, de Graaf R, Korf DJ, van         den Brink W, van Laar M.
Drug Alcohol Depend. 2013 Dec
76. Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.
Verrico CD, Haile CN, Newton TF, Kosten TR, De La         Garza R.
Expert Opin Investig Drugs.         2013 Dec
77. Towards a better cannabis drug.
Mechoulam R, Parker L.
Br J Pharmacol. 2013 Dec
78. Exercise increases plasma THC concentrations in regular cannabis users.
Wong A, Montebello ME, Norberg MM, Rooney K,         Lintzeris N, Bruno R, Booth J, Arnold JC, McGregor     IS.
Drug Alcohol Depend. 2013 Dec
79. Cannabis dependence, cognitive control and attentional bias for cannabis words.
Cousijn J, Watson P, Koenders L, Vingerhoets WA,         Goudriaan AE, Wiers RW.
Addict Behav. 2013 Dec
80. Emerging adulthood themes, role transitions and substance use among Hispanics in Southern California.
Allem JP, Lisha NE, Soto DW, Baezconde-Garbanati L,         Unger JB.
Addict Behav. 2013 Dec
81. A longitudinal examination of alcohol, marijuana, and cigarette perceived norms among middle school adolescents.
Pedersen ER, Miles JN, Ewing BA, Shih RA, Tucker JS,         D’Amico EJ.
Drug Alcohol Depend. 2013 Dec
82. Perceived stress and substance use in methadone-maintained smokers.
Moitra E, Anderson BJ, Stein MD.
Drug Alcohol Depend. 2013 Dec
83. The association between problematic parental substance use and adolescent substance use in an ethnically diverse sample of 9th and 10th graders.
Shorey RC, Fite PJ, Elkins SR, Frissell KC, Tortolero         SR, Stuart GL, Temple JR.
J Prim Prev. 2013 Dec
84. Marijuana use is associated with inattention in men and sleep quality in women with Attention-Deficit/Hyperactivity Disorder: A preliminary study.
Ly C, Gehricke JG.
Psychiatry Res. 2013 Dec
85. Impact of ADHD and cannabis use on executive functioning in young adults.
Tamm L, Epstein JN, Lisdahl KM, Molina B, Tapert S,         Hinshaw SP, Arnold LE, Velanova K, Abikoff H, Swanson JM; MTA         Neuroimaging Group.
Drug Alcohol Depend. 2013 Dec
86. Pregabalin abuse among opiate addicted patients.
Grosshans M, Lemenager T, Vollmert C, Kaemmerer N,         Schreiner R, Mutschler J, Wagner X, Kiefer F, Hermann       D.
Eur J Clin Pharmacol. 2013 Dec
87. Is the relationship between early-onset cannabis use and educational attainment causal or due to common liability?
Verweij KJ, Huizink AC, Agrawal A, Martin NG, Lynskey         MT.
Drug Alcohol Depend. 2013 Dec
88. Attention problems in childhood and adult substance use.
Galéra C, Pingault JB, Fombonne E, Michel G, Lagarde         E, Bouvard MP, Melchior M.
J Pediatr. 2013 Dec
89. Cumulative and recent psychiatric symptoms as predictors of substance use onset: does timing matter?
Cerdá M, Bordelois PM, Keyes KM, Galea S, Koenen KC,         Pardini D.
Addiction. 2013 Dec
90. Oral Fluid Cannabinoids in Chronic Cannabis Smokers during Oral Δ9-Tetrahydrocannabinol Therapy and Smoked Cannabis  Challenge.
Lee D, Vandrey R, Mendu DR, Anizan S, Milman G,         Murray JA, Barnes AJ, Huestis MA.
Clin Chem. 2013 Dec
PMID: 23938457 [PubMed – in     process]
91. Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study.
Feinshtein V, Erez O, Ben-Zvi Z, Eshkoli T, Sheizaf         B, Sheiner E, Holcberg G.
Am J Obstet Gynecol. 2013 Dec
92. [Motivations for cannabis cessation, coping and adaptation strategies, and perceived benefits: Impact on cannabis use relapse and abstinence].
Chauchard E, Septfons A, Chabrol     H.
Encephale. 2013 Dec
93. Factors associated with variability and stability of cannabis use in young adulthood.
Silins E, Hutchinson D, Swift W, Slade T, Toson B,         Rodgers B.
Drug Alcohol Depend. 2013 Dec
94. A longitudinal examination of psychological, behavioral, academic, and relationship consequences of dating abuse victimization among a primarily rural sample of adolescents.
Foshee VA, Reyes HL, Gottfredson NC, Chang LY, Ennett         ST.
J Adolesc Health. 2013 Dec
95. Do cannabinoids exhibit a tyramine-like effect?
Ilayan E, Feliszek M, Malinowska B, Schlicker         E.
Naunyn Schmiedebergs Arch         Pharmacol. 2013 Dec
96. Cannabinoids decrease the th17 inflammatory autoimmune phenotype.
Kozela E, Juknat A, Kaushansky N, Rimmerman N,         Ben-Nun A, Vogel Z.
J Neuroimmune Pharmacol. 2013 Dec
97. Illicit and nonmedical drug use among Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals.
Wu LT, Blazer DG, Swartz MS, Burchett B, Brady KT;         NIDA AAPI Workgroup.
Drug Alcohol Depend. 2013 Dec
98. Predicting the         transition from frequent cannabis use to cannabis dependence: a         three-year prospective study.
van der Pol P, Liebregts N, de Graaf R, Korf DJ, van         den Brink W, van Laar M.
Drug Alcohol Depend. 2013 Dec
99. Menthol cigarette and marijuana use among adolescents.
Kong G, Singh N, Camenga D, Cavallo D, Krishnan-Sarin         S.
Nicotine Tob Res. 2013 Dec
100. Cigarette smoking and quit attempts among injection drug users in Tijuana, Mexico.
Shin SS, Moreno PG, Rao S, Garfein RS, Novotny TE,         Strathdee SA.
Nicotine Tob Res. 2013 Dec
101. Health literacy and         substance use in young Swiss men.
Dermota P, Wang J, Dey M, Gmel G, Studer J,         Mohler-Kuo M.
Int J Public Health. 2013 Dec
102. Adolescence to young adulthood: when socioeconomic disparities in substance use emerge.
Widome R, Wall MM, Laska MN, Eisenberg ME,         Neumark-Sztainer D.
Subst Use Misuse. 2013 Dec
103. Peripheral endocannabinoid system dysregulation in first-episode psychosis.
Bioque M, García-Bueno B, Macdowell KS, Meseguer A,         Saiz PA, Parellada M, Gonzalez-Pinto A, Rodriguez-Jimenez R, Lobo A,         Leza JC, Bernardo M; FLAMM-PEPs study—Centro de Investigacio´n         Biome´dica en Red de Salud Mental.
Neuropsychopharmacology. 2013 Dec
104. Internet and computer based interventions for cannabis use: a meta-analysis.
Tait RJ, Spijkerman R, Riper H.
Drug Alcohol Depend. 2013 Dec
105. Childhood conduct disorder trajectories, prior risk factors and cannabis use at age 16: birth cohort study.
Heron J, Barker ED, Joinson C, Lewis G, Hickman M,         Munafò M, Macleod J.
Addiction. 2013 Dec
106. Prevalence and correlates of heavy smoking and nicotine dependence in adolescents with bipolar and cannabis use disorders.
Heffner JL, Anthenelli RM, Adler CM, Strakowski SM,         Beavers J, Delbello MP.
Psychiatry Res. 2013 Dec
107. Electroconvulsive Therapy (ECT) for Catatonia in a Patient With Schizophrenia and Synthetic Cannabinoid Abuse: A Case Report.
Leibu E, Garakani A, McGonigle DP, Liebman LS, Loh D,         Bryson EO, Kellner CH.
J ECT. 2013 Dec
108. Genes and environments in schizophrenia: The different pieces of a manifold puzzle.
Réthelyi JM, Benkovits J, Bitter     I.
Neurosci Biobehav Rev. 2013 Dec
109. Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors.
Pryce G, Cabranes A, Fernández-Ruiz J, Bisogno T, Di         Marzo V, Long J, Cravatt B, Giovannoni G, Baker D.
Mult Scler. 2013 Dec
110. Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings.
Sánchez-Torres AM, Basterra V, Rosa A, Fañanás L,         Zarzuela A, Ibáñez B, Peralta V, Cuesta MJ.
Eur Arch Psychiatry Clin         Neurosci. 2013 Dec
111. Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ(9) tetrahydrocannabinol.
Wright MJ Jr, Vandewater SA, Taffe       MA.
Br J Pharmacol. 2013 Dec
112. Adolescents’ attitudes toward antimarijuana ads, usage intentions, and actual marijuana usage.
Alvaro EM, Crano WD, Siegel JT, Hohman Z, Johnson I,         Nakawaki B.
Psychol Addict Behav. 2013 Dec
113. Associations between IQ and alcohol consumption in a population of young males: a large database analysis.
Müller M, Kowalewski R, Metzler S, Stettbacher A,         Rössler W, Vetter S.
Soc Psychiatry Psychiatr         Epidemiol. 2013 Dec
114. Coping styles and illicit drug use in older adults with HIV/AIDS.
Skalski LM, Sikkema KJ, Heckman TG, Meade         CS.
Psychol Addict Behav. 2013 Dec
115. White and black adolescent females differ in profiles and longitudinal patterns of alcohol, cigarette, and marijuana use.
Chung T, Kim KH, Hipwell AE, Stepp       SD.
Psychol Addict Behav. 2013 Dec
116. Psychosocial and demographic correlates of drug use in a sample of HIV-positive adults ages 50 and older.
Siconolfi DE, Halkitis PN, Barton SC, Kingdon MJ,         Perez-Figueroa RE, Arias-Martinez V, Karpiak S, Brennan-Ing         M.
Prev Sci. 2013 Dec
117. Is psychotic disorder associated with increased levels of craving for cannabis? An Experience Sampling study.
Kuepper R, Oorschot M, Myin-Germeys I, Smits M, van         Os J, Henquet C.
Acta Psychiatr Scand. 2013 Dec
118. Confounders of excessive brain volume loss in schizophrenia.
Van Haren NE, Cahn W, Hulshoff Pol HE, Kahn         RS.
Neurosci Biobehav Rev. 2013 Dec
119. Characteristics of northern plains american indians seeking substance abuse treatment in an urban, non-tribal clinic: a descriptive study.
Kropp F, Somoza E, Lilleskov M, Moccasin MG, Moore M,         Lewis D, Boetel B, Smith C, Winhusen T.
Community Ment Health J. 2013 Dec

About josiahe

Watching closely, working to understand all I may, in this "Age of Information", even from my limited view, I can see much of what's going on ..... and I oft see it's going to impact all of us which is why I share it. My focus is to expose evil, and to serve my Lord and savior Jesus in whatever way He shows me. If one waits long enough, better writers will come along and comment; it's just that I have so little patience with the evil that lurks among us and I've wasted so much time and now, there is so little left! WELCOME!
This entry was posted in a href="">search engine submission, Marijuana, Pot, Uncategorized and tagged , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s